DHG Pharmaceutical JSCSTC:DHG -0.11%78 FCF Yield % is 6.70 as of Jun. 27, 2026, which is 45% above its 10-year median of 4.62. GuruFocus rates STC:DHG with a GF Score™ of 78/100 and a GF Value™ of ₫113,390.11 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,005 Drug Manufacturers companies, DHG Pharmaceutical JSC ranks better than 79.4% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
DHG Pharmaceutical JSC FCF Yield % Related Terms
DHG Pharmaceutical JSC FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DHG Pharmaceutical JSC FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's FCF Yield % distribution charts can be found below:
* The bar in red indicates where DHG Pharmaceutical JSC's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHG Pharmaceutical JSC (STC:DHG) has a FCF Yield % of 6.70 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DHG Pharmaceutical JSC and its competitors. This is 45% above median its historical median of 4.62. According to the industry distribution chart, DHG Pharmaceutical JSC ranks #207 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 20.6%.
Is DHG Pharmaceutical JSC's FCF Yield % too high?
DHG Pharmaceutical JSC's current FCF Yield % of 6.70 is 45% above median its 10-year median of 4.62. The Drug Manufacturers industry median FCF Yield % is 0.67. DHG Pharmaceutical JSC's value of 6.70 is 900% above this industry median. Based on the distribution chart, DHG Pharmaceutical JSC ranks #207 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, DHG Pharmaceutical JSC has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's FCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, DHG Pharmaceutical JSC ranks #207 out of 1005 companies for FCF Yield %. This places DHG Pharmaceutical JSC in the top 21% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.67. DHG Pharmaceutical JSC's value of 6.70 is 900% above this benchmark. While the company's 10-year median is 4.62 vs. the industry median of 0.67, DHG Pharmaceutical JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DHG Pharmaceutical JSC's current FCF Yield % of 6.70 is 900% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DHG Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DHG Pharmaceutical JSC's current FCF Yield % is 6.70, which is 45% above median its own 10-year median of 4.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,390.11, compared to a current price of ₫93,800.00 — trading 17.3% below its estimated fair value. The current FCF Yield % is 6.70, which is 45% above median its 10-year median of 4.62 and 900% above the Drug Manufacturers industry median of 0.67. DHG Pharmaceutical JSC's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current FCF Yield % is 6.70 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued.
The current stock price of ₫93,800.00 is trading 17.3% below its estimated GF Value™ of ₫113,390.11.
GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.
Key valuation signals for STC:DHG:
FCF Yield %: 6.70 (45% above median its 10-year median of 4.62)
GF Value™: ₫113,390.11 vs. price of ₫93,800.00 (17.3% below fair value)
Industry Position: 900% above the Drug Manufacturers median (#207 of 1005)
No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
78GF Score
Get the complete analysis for STC:DHG
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DHG has been successfully added to your 
